Trial · NCT07892261
Effectiveness of Topical Fluoroquinolone Gel in Treating Stage II/III Periodontitis
NCT07892261, Not applicable, Completed, Naira Mohammed
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effectiveness of Topical Fluoroquinolone Gel in Treating Stage II/III Periodontitis. Trials, record NCT07892261. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892261
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effectiveness of Topical Fluoroquinolone Gel in Treating Stage II/III Periodontitis
- NCT number
- NCT07892261
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 20 participants, actual
- Lead sponsor
- Naira Mohammed
- Conditions
- Stage II and III Periodontitis
- Interventions
- Levofloxacin in-situ gel, Professional mechanical plaque removal
- First posted
- 2026-10-23
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Probing depth | Up to 6 months. | To assess changes in probing depth using William's probe, measuring it from the base of the pocket up to the gingival margin. A decrease in probing depth readings indicates improved clinical outcomes. |
| Primary | Clinical Attachment Loss | Up to 6 months | To assess changes in clinical attachment loss using William's probe, measured from the base of the pocket up to the gingival margin, then the distance between cemento-enamel junction to the gingival margin is measured. The second measurement is then deducted from the first one to calculate clinical attachment loss. During follow-up, a decrease in this figure represents gain in attachment, hence healing. |
| Primary | Modified Gingival Index | Up to 6 months | Using a scale from 0 to 4, visual assessment is used to grade the gingival index, with a score of 0 representing normal gingiva, up to a score of 4 representing the most inflammed tissue. |
| Primary | Bleeding Index | Up to 6 months | A scale from 0 to 3 is used to grade bleeding index. Using a probe, you gently pass along the gingival margin to check the presence and grade of bleeding. 0 represents no bleeding, 3 represents profuse bleeding in the intended area. |
| Primary | O'leary Plaque Index | Up to 6 months | It's graded by a scale ranging from 0 to 3, with 0 representing no plaque and 3 representing heavy plaque seen by the naked eye. William's probe is used to gently move in a brushing motion along the gingival margin to detect any plaque. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07892261
GET https://conductscience.org/api/trials/v1/NCT07892261/registered